Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials — Marco Proietti (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials
Shared by
Professor Gregory Lip
University of Liverpool
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials
Article
2016
en
Authors
MP
Marco Proietti
Professor Gregory Lip
University of Liverpool
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2016
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
Marco Proietti
,
Deirdre A. Lane
,
Professor Gregory Lip
Article
2016
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
Marco Proietti
,
Keitaro Senoo
,
Deirdre A. Lane
,
Professor Gregory Lip
Article
2017
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials
Marco Proietti
,
Professor Gregory Lip
Article
2017
5741Use of aspirin and impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials
Marco Proietti
,
Professor Gregory Lip
Article
2016
Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin
Keitaro Senoo
,
Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.